Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Wenxi Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3564-3626; OpenAlex author ID A5037377894. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. … Last author DOI 10.1186/s12962-024-00578-5↗
  2. Hedgehog-Gli1-derived exosomal circ-0011536 mediates peripheral neural remodeling in pancreatic cancer by modulating the miR-451a/VGF axis. Co-author DOI 10.1186/s13046-023-02894-9↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanqiao Shao · 1 shared paper, 2024 · strength 0.26
  2. Xuanfu Xu · 1 shared paper, 2023 · strength 0.18
  3. Xiaorong Xu · 1 shared paper, 2023 · strength 0.18
  4. Weiqi Dai · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.